Basel City Guide

Switzerland's life-sciences capital and a tri-border hub where the country meets Germany and France, Basel anchors its property market on one of the world's most resilient employment bases: the global headquarters of Roche, Novartis and Lonza, plus a dense pharmaceutical and biotech cluster that draws high-earning international professionals. This translates into exceptionally tight housing, with citywide vacancy below 1.2% and the Gundeldingen and St. Johann quarters running below 0.5%. Residential prices average roughly CHF 8,500 per square metre, with prime hillside addresses such as Gellert, Bruderholz and St. Alban, and the ultra-prime suburb of Riehen, reaching CHF 9,500–CHF 10,500 and beyond. As is typical for Switzerland, yields are modest and income-led: gross rental yields range roughly 3.0–4.2%, with the strongest returns in mid-market areas like Kleinhüningen, Matthäus and parts of Iselin, while prime apartments compress toward 2.4%. Prices are expected to appreciate a measured 2–4% through 2026, tracking slightly below Zurich. Basel is not a market for aggressive capital growth or speculative flips; rather, its structurally stable pharma employment, sub-1% vacancy and Swiss-franc safe-haven status make it a premier choice for conservative investors prioritising capital protection and consistent rental income.